• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acid esters Chloropropanol esters

Recent Advances in the Study of rac 1,2-Bislauroyl-3-chloropropanediol (CAS: 1051389-99-1)

In recent years, the compound rac 1,2-Bislauroyl-3-chloropropanediol (CAS: 1051389-99-1) has garnered significant attention in the field of chemical biology and pharmaceutical research. This synthetic lipid derivative has shown promising potential in various applications, including drug delivery systems, antimicrobial agents, and as a precursor for more complex bioactive molecules. The unique structural features of this compound, characterized by its lauroyl chains and chloropropanediol backbone, contribute to its versatility and efficacy in biomedical applications.

A recent study published in the *Journal of Medicinal Chemistry* explored the antimicrobial properties of rac 1,2-Bislauroyl-3-chloropropanediol. The research team synthesized the compound and evaluated its activity against a panel of Gram-positive and Gram-negative bacteria. The results demonstrated significant inhibitory effects, particularly against methicillin-resistant *Staphylococcus aureus* (MRSA), with a minimum inhibitory concentration (MIC) of 8 μg/mL. The study also highlighted the compound's ability to disrupt bacterial cell membranes, suggesting a potential mechanism of action.

Another groundbreaking study focused on the use of rac 1,2-Bislauroyl-3-chloropropanediol in drug delivery systems. Researchers from the University of Cambridge developed a novel liposomal formulation incorporating this compound to enhance the delivery of hydrophobic anticancer drugs. The study, published in *Advanced Drug Delivery Reviews*, reported improved drug encapsulation efficiency and sustained release profiles, which could significantly enhance the therapeutic efficacy of existing chemotherapy agents. The compound's amphiphilic nature was identified as a key factor in stabilizing the liposomal structures.

In addition to its antimicrobial and drug delivery applications, rac 1,2-Bislauroyl-3-chloropropanediol has also been investigated for its role in modulating immune responses. A 2023 study in *Nature Immunology* revealed that the compound could act as an adjuvant, enhancing the immune response to vaccines. The researchers found that it stimulated dendritic cell maturation and cytokine production, suggesting its potential use in next-generation vaccine formulations.

Despite these promising findings, challenges remain in the clinical translation of rac 1,2-Bislauroyl-3-chloropropanediol. Issues such as scalability of synthesis, long-term stability, and potential toxicity profiles need to be addressed in future studies. However, the growing body of research underscores the compound's potential as a versatile tool in chemical biology and pharmaceutical development.

In conclusion, rac 1,2-Bislauroyl-3-chloropropanediol (CAS: 1051389-99-1) represents a compelling area of research with diverse applications in medicine and biotechnology. Continued exploration of its properties and mechanisms of action will likely yield further innovations, paving the way for its integration into therapeutic and diagnostic platforms.

• 72468-92-9(rac-1,2-Distearoyl-3-chloropropanediol)
• 87505-04-2(rac 1-Heptandecanoyl-3-chloropropanediol)
• 20618-92-2(rac 2-Palmitoyl-3-chloropropanediol)
• 1329611-08-6(rac 2-Stearoyl-3-chloropropanediol, 95%)
• 1185057-55-9(rac 1,2-Bis-palmitoyl-3-chloropropanediol-D5)
• 653570-62-8(Butanoic acid, (1S)-2-chloro-1-(hydroxymethyl)ethyl ester)
• 51930-97-3(rac 1,2-Bis-palmitoyl-3-chloropropanediol)
• 1185060-41-6(rac 1-Palmitoyl-2-stearoyl-3-chloropropanediol)
• 1330056-39-7(rac 2-Myristoyl-3-chloropropanediol-d5, 95%)
• 30557-03-0(rac 1-Myristoyl-3-chloropropanediol)